The Effects of Ten Weeks Resistance Training on Resting Levels of Some Angiogenesis Factors Among Men with Prostate Cancer

/

129

96

: *

! " ! # $ ! %

.

md.faramarzi@gmail.com: ( ) *#%'

! " # $ % &' () * +, '

1

*

2

!" 3

4

1 -

!" # $% &

' ! % ( ) .

2 -

' ! % ( ) !" #

.

3 -

' ! % ( ) -! . / 0 ! ! $/

.

4 -

! $/

' ( ) 2 % 3 4 5! .

! ' .

! / #

$ % / #

4 / '!

96 / *+ + 73

: 3 / 7 / 96 :

29 / 8 / 96

$ :

! & ' ( ) *+, -. / & ( ( &!0 1 -. ( 2! 1 3 &!0 1 .

! 1! 5' 6 7,! ' 68 9': ;!3 <' (

1 -' = >8 ( &!0

. ( 2! 1 3 &!0 1 ? @ & ( ( 6 : 'A B , C !$ -' ; D E( .FĤ; 1 H.$ ; -' I .

(

=

!:

20 K1 K ( ! 2! 1 3 &!0 1 ? @ ( 55

!;

62 N KO E 8 ( (!P; 2 Q R!S N!1 )

10 D (

!$

) 10

D ( V.>$;

. 2 W; E 8 10

( ( X!W !$ -' ; >+Y 1 D -' ; D .

2 ! Z; E( ( ! ( 1 -' ; 50

!;

65 X!W K./. Z; 9' Q ( .

48 @\ *,!1 48

]3 -' ; Z; 3 Y ^ *,!1 12

C ! ! *,!1 E * Y

_ , !.+; !, .8 )

(VEGF *1? @. !, )

(FGF '!>O 9' . )

(NO 8 . 8 -. 8 & ( 2 ..`;

* 8 \ .+ ; '6W; ( $ > ; > ; & B E(!D 1 ! a.; ;

.

'

!

!:

X!W ( ( &!/ b'!

10 c1 ( ( K^ 5' 6 7,! !$ -' ; D VEGF

) 0001 / 0 (P=

)FGF 0001 / 0 (P=

)NO 0003 / 0 (P=

2! 1 3 &!0 1 ? @ & ( ( N KO E 8 *@> W; E 8 (

.

7 W.

.8 :

1 e 10

!$ -' ; D 6 : 'A B , 5' 6 7,!

2 \ & ! . ( f >C 5 !O ? , E( ;

(( 8 2! 1 3 &!0 1 ? @

.

E:

! .+O :

6 : 'A B 2! 1 3 &!0 1 !$ -' ;

.

/

130

96

$

C D6 D 4 D6 $/ . ' E / ' D6 D 6

!< 6 3 - / / )

1 .(

D9 6< 4! D>< H D/

D/ D $06 I

2010 ' D6 D9 ' E D/ 4 D

DD -$> 0DD ' E DD/ 4! DD K! DD $DD/ . ' E DD/

L ' " 6 4! $ )

28 N ( C 6 4 6

6 ) 11 N ( O DP$> D> - -! ' E / 5.

/ ) 2 .(

/ <

42 ' D6 N 50

-D I D/

9 9 - &! A> R $D/ . ' E D/ S! $

) 2 .(

$/ . ' E /

"

0 39 )!

' E / D9 T D>

U >

! U >

' 6

! U/V. W '

D6 > X D09

3 / ) 3 .(

9 6 U >

$ 1 2

6

$6 YZ 6 06

D[ \ ]D D! ^

D

4 6 '; % 6 _`6 0$ 9 .

% / -%

Y^ 6 -D

^ ' 6<

4!

a!

# 6 D6 D D

" !; <

) -

^ ' 6<

C ! 6 9 D! ^ C ! D6 D9

][

( b ] ) 4 .(

U c0 d"D^ % e 9 a/ " !; <

'; D % 4 6 -% / S $/ 39 9 U 6 3(6 - / -

! 3 6 a] 6 $6 9 - f )

5 .(

D [ a/ !_g 6 '; % - / $/ 9 6 Dh6 0$ 9 i I ? / - -% ! ( / 4 D(6 R D $# D 4 D D # D - " 9 $6 $

DD6 DD ) 6 .(

DD6 ' DD % e 9 -DD kDD/ .

# DD9 I DD/ aDD/ " DD!; < DD00% SDD! h DD9 $%

D> f D ! ^ > K]06 = 6 D9 I / i ' 6 -% 00% 6 7 ^ 6

/ l i A h6 6

) 7 .(

I / 1945

& <

o 4 D % D

-D%

0$# ! 6

\Z/

S!

\ ] [ -D

" !; <

-$

/

\9 .

1970

"

S ".

@ ^ 43 #

4

% -%

p # q D9 % D

KD]06 D>

r! E

^ " D!; <

-D sD[

D D6 D$?

So % '

'<

6 &06 6

W

"

SD !; <

t u /

"

0Z!

U c0 I Z 4 I D 6 D9 SD !; <

$ <

S !; <

a h6 So % 6 -$# !_.

D D/

.

6 )09 -D%

D9 $% # SD !; <

D : D =D6 D$ <

-] g S !; <

D0%

D6 D 9 6 SD !; <

-D D/

6

<

-

= C D9 D>

D! ^ D

D6

D6 D6 &

5 D . I D 6 D9 SD !; <

D$ <

S !; <

-%

I / 9 E / -3 o / 6

D D

L 6 =h6

` 6 00%

. 4!

I 6 9

# .

6

"

!_. ` )

8 .(

! U(6 4!

=6 S !; <

$% # I

DD[

) (VEGF

DD/

-DD%

DD[

DD ' DD$ 6 4!

DD

O Pv6 I /

9

I D

D ' D 6 35 D 45

6 ' $ % .

% e! 9

\Pv 6 D6

D/

% e! 9 I /

9 E / 6 D SD!

w Dh6 UD(6

) VEGF

9 .(

4D!

SD! h YD^ 6VEGF

D

^ (6 7

I / 9

I D

-D& $ $D

T

$

\ ] [ 6

6 6 SD! h $D

9 $% #

$ <

!; <

- ] 9 $% # D!; <

- 29 %

" !; <

6 6 &

-& $ Y]/

s[

6

$?

6 '<

) 9 ( 0 D D9 29 ;. .

27

$ <

S !; <

9 ' 6

' E / '

D/

' 0%

$ <

S !; <

- . ' D0 T D6 : D6

8$/

6 -%

' 6 4 $D/

D ! 4! :xD6

/ ( <

.

$ <

S !; <

E a!

O >

=i6 3 9 D!

T h : [ 6 @ A/ ` .

VEGF

E

yZ 3 9

=i6 3 9 D] [ ]DP D[ -

u 6 [ Do -D ' E D/

;D!

' E D/

D9 -0 D/

$/ . -!

zv 6 D

D/

) 10 .(

4 D0{39

VEGF

I D 9 I / 5 ! 6 -!"& i ^ (6

! % S! $ - 3^

) (NO

6 )

11 .(

D % SD! $

/

131

96

0D/ D % SD! $ aD/ NO

$

<

D

D SD . . D00% U Dc0 S! ' 0 - "$0/

=3 ! ' E / 0% 6

. ' D0 -D R 3Z6 % S! $

D0% D6 =3 -] 3 S!

. D)! D ! 4 D0{39

" DD!; < DD9 z> DD DD DD6FGF

. DD =DD6

! /V ] #

FGF

0D D6 D =6 > 9

D9 UD> ' 6 " !; <

D 2D7 D0 0^ -ZD/

.

FGFs

"! D3 T $D 9 0!< # % 27 sD E

D D9 D# D9 I / $ =D6 29 D%.

VDy sZl -& $ Vy 29 % | FGF

6 3 ^ ! ( )

12 .(

C -D% ! D& <

D6 D D D6 ' ' D> ' D! ^ ! !

6 l

) 13 ( - l # D)09 -D -% 6 '

I DZ# Vy 6 a h6 "! 4 9 Z#

$ D[ _D`6 D6 '; D % ' D> KD! 06 ( 29 D% D6 ' D> ' ! ^ -% ! & < 6 N 6 } D6 D 6 3D [ ; D % U% ~ ][ Z$6 ! D ! D6 2!"D# D6 D$. .< L D[ I 3$? 9 6

) 14 .(

' D3 D]( (^ 8$6 6 9 =3 6 6

D6 8$D/ $D/ . ' E / - V$]6 D

. 4D! D !

4! 3 - 3^ 0! 3 8$/ 9 $6 D76

6 . D9 3D [ ! 9 / $6 76 4! 3

0% 6 &! ' s $v6 .

- Dy 9 ] # ` I 7$

- Dy # e! D9 SD! L D D9 ] # O P> - $ / D: D% 4 D? - Dy )$ > ^ $ / 6 & $6 76 0! 3 )09 -% 3(6 2!"D#

6 Vy # - ' > ' ! ^ ! )

1 .(

D 4 D0{39

' D> ' D! ^ 2!"D# | $6 76 0! 3 - 0! - -^

D!" 0! 3 ! / - ] 6 6 Vy # - D -% $3%

D YD/ 06 ' E D/ -D V$D]6 D#

6 ) 15 .(

D 39 " D^ $/ 4!

-DZ A6 ' 29 % | 9 4! 3 '

D6 # VEGF

# 2!"

]D D6 ' : Vy VEGF

D9 T 6 I $0% - $D/ . ' E D/ -D V$D]6

6 ) 16 ( . ' D 39 D( B$D# 4 D0{39 D7 7h

Z6 2!"D# | $6 76 4! 3 ' @ AD/ D0

VEGF

D D6 ' $ . ' E / - V$]6 ' FGF

) 17 .(

D0! 3 D: D/ -D -Z A6 " ' 39 6 @ AD/ D $6 7$/

-D V$D]6 D9 T D6 $# D VEGF

0$> . ' $ . ' E / .

D 9 DZ ' D ( < •! $

@ A/ $6 7$/ 4! 3 -$89 9 T 6 VEGF

- V$]6

29 D% 9 T 6 4! 6 U&? 29 % ' $ . ' E / 0Z6 )

18 .(

' E D/ -D V$]6 ' 3

4 8 D % 6 c 9 6 =? 6 Z $/ . D!" Dl D[ =D6 S! 4! -% 00% 6 8$/

DD/

. sZDDl DDo DD]( DDZ ' DD3 4DD!

VDDy

D D6 D9 q P6 )$ >

) 19 .(

D7 7h

D6 =D? 6 D& DZ ' 3 ' s $v6 D D -D% D 6 Vy sZl )$ > o " D!; < =D6 29 D% D -D ' - # % / ' >

rD! Z -D D# 4! =6 % ]( 6 / D

) 19 .(

|D " !; < =6 2!"# -% - l # 4! - -^

D D6 "D Z# 6 6 2!"#

: D D/ rD 7h 4! q 9 =6 4! ` | ' D6 " !; < =6 > $6 76 4! 3 -$89

$/ . ' E / - V$]6 .

(

=

!

D& D 6 N - -% & -3 29 ;. 4!

8$/ € h - # D% D6< D/ -D •! $

6 . ' 6 l ? r 7h 9 6 <

55 62 - /

> ( - D D6 = $/ . ' E / - V$]6 <

> ( PPv "% 6 . -%

<

. 5D.

- 9 / )09 39 62

% D a! "u ? 8

/

132

96

D( < D/ =Dh6 H < 48 3 29 ;.

D6< =3 - 29 ;. 4! y? ( < ]:

.

3 / (# $ 29 ;. 4! 9 6 < • v$

=[ ? ( < $/ . ' E / -%

D Dh6 =][ 6 S!

U D> T D> ' E / # / •! $ - -^

DPPv "D% 6 D D $/ $6 - ? 6

< K3^ Pv 9 YA6 .

R D76 ! / -Z A6 6 9 - 3 / - -^

H $/ 9 - 3 )

-% 9 6 <

a! D -D -^

3 39 V r 7h (

DZ 20 Dl ? D8

39 - .

D# 29 ;D. D^ =D? 6 q D9 B! D 5.

% D D# 3 a/ r 7h 4! % -6 ! l D! =D 3 SD! -D^ D> y ! 00%

.

$ 6 VE ' 00% % - % 29 ;D. O DP> •

'< -DZ A6 5D. D3 # ! D D/ > D9

! l -6 0! 3 y6 ]$%

. D6 D[V> D9 &6

D 9 ;. fVD> -D$ 3% 29 ;D. 4D! D^ D D _> % ( ) .

UD9 29 ;D. =D? 6 -D % 4 0o

D !" # ' DPPv$6 zDPv$6 SD ". Dc ! l ? &

. 6 < - % t D9 SD ". ! 9

-D

3 -0 . =D3 -D 9 & [ ] [ 9

D]% % 9 3 ! R ' > # ? ^ 0$ r 7h 9 `$6 _ : .

D[ D D( 6 < [

D[ D •0/

01 / 0 D D( < ' D$6 D[ D D

1 / 0

% .

r [ 4 Z (^

D z> D

' DD

(BMI)

5DD.

12 ! $DD DD/

' U DD 7

)

% ( [ _&6 - )

$6 ( 6< / . 4! D3 D6 E

zDPv$6 S ". a/ "! & 9 &

% 6 q P6 .

A6 ƒ > 9 Z6 =6 D -DZ

:

1 - D6 ' D < 6 3 6 . &

2 - D? ^ -D 9 &

3 - D3 -D 9 4$D ] [

4 - D D 6 ) D/ ' q P6 5

- 4$D

"`6 . V 6 =i6 3 ^ = 6 -% ]P –

T K 6 .

6 - D$3% ' > # 110

/ 180 7 -

PSA

$ 7

$ 8 - -D% $D/ . ' E / - V$

z v # / )$/ r! E .

6 ! a! ". . - / 4 0{39 SD! 9 D6 ! 6 ! -{ 0o # [ -^

29 ;D. % D D D% D6 f DN ' 3 6< 3 =3 - :

D> # . ! ] [ 3

I $0% = [ g )

$D / ' > # 140mmHg

D #

D UD% $D/ ! ' D>

90mmHg

(

DD u D3

D ` D03! D! 6 9 &09 8 09… 3 ' "DD 6 -DD ' 10

% 2 DD DD!

10 % 6 -$DD _ DD6

$/ $6 -D6 9 '< % -% 6 - 9 ' %

! 3 =$v6 $6 76 4! 3 .

I D$0% - # P E - # 4! 5e/

) 10

8 ( $6 76 0! 3 )

10 8 ( U 7 .

D& =][

H / / 4)39 c06 - - > 6 D[ 4/

' DD3 ' DD6 DD6 DD DD z> DD

) ( BMI

DD

D0Z6 D8 -% ! zv 6 - ! 76 )! ! ^ ( < 4 )

I ^ 1 .(

!$ -' ; !

=6 D $6 76 4! 3 10

-D$89 D9 -D$89 3

-D ^

4! 3 . =6 4! 3 -6 10

L D D ' % -7 [

DD& 5eDD/ DD 6 DD % DD% ? DD% ? DD 9

6 - ! N - 9 )$ ! 25

30 D -D7 [ .

" ($

10 -$# c ' % / -7 [ .

)$D !

D% ? -0 D/ H D. D. H . =6 Y - 0! 3 9 9 ' % U> ! . )

' .

( D D . - /

' % )

' ^ ( D D D ^ .

D9 4! D3 -D6

D D D D -D/ =6 - ^ 50

D 65

-0 S! N

. D9 )$D ! 4 ? $/ ' 6

/

133

96

45 60 9 4 ? $/ ' 6 - : 90

Dc - :

-$#

. D9 DZ ? E - - -# l =N

< S! 4! 3 -$89 4! D3 D9 -0 ' 6

76 -$# c 5

% -# l - .

SD! 4 D Z D

8$/ ! I 6 # -0 )

1 .(

'!. . . ! .` .8 E .8 & C

> - 3 48

=][ / 48

4! D>< DZ D/

' " 6 - 4! 3 - ^ 5

KD3^ D/ / D <

. -D 3

> 9 2000rmp

6 - 10 D^ D -D7 [

D 8! $ / / / .

D9" < D D/ 5eD/

;D! D9 q ‡ r 7h c 6 9 z> Z "D! # - N #V K! q 0.

80 - D $ D/ -D^

() .

2&0/ (^

% VEGF

3) / ) D <

t!

! D ! 6<

( D/ ? D

pg/ml

6 / 3 ' D/ ? D

DD9 1 / 3 -٪

5 / 3 2&0DD/ DD(^ ٪

2&0DD/ DD %NO

' " 6 )NO

! % S! $ (

' D3 < % D De3% I Ph6

DD/ ? DD YDDE 4 DD. % DD aDD/ DD -DD ( 1 / 1 2&0/ (^ $ I 6 6 % D % FGF

") 9 D/ ? D 4 Do

pg / ml

39 / 0 D 6CV

/ 5 D ٪

8 / 3

! 8$/ ٪

. )$D/ 8$/ r 7h 9 `$6

"!R

STAT FAX

2100 D9 D % 4. % > /

&0/ O Pv6 .

! B .+ ; '6W;

8$/ 9 = h -!"&

SPSS

2! ! 19 &

! . D9 z> 9 s N "D% 6 s DN

8$D/ E ]0$/ 6< 9 4 ) 6 - ! 76 0% . .

$ c06 4!

D 8$D/

' D6 <

q D3 % -

q 3/

K!

Z ]E 9

/ . -^

- Z ]E '

K!

(^ 9 /

D9 D8 4 D

D9

' - 9 Y

' 6 <

=7$ 6t

-$

8$/

.

!'

!

I ^ ^ 6 VE - -^

1

& 6

4 ) 6 - ! 76 2 . 9

5. ' 6 <

6 ' ' 6 <

-% 9

'" 6

& Z # VEGF

0Z6 2!"# 0! 3

-$

76 - -^ -%

6< / t

15 / 3 BA/

0Z6 0001

/ 0 0Z6 ` '" 6 4!

6 .

N Y 1 . ^ @\ E .8 E ! .` ( 2 ..`; >'!$

!$ -' ; +C D */

.`

E 8 5.3

& B

& B ]3 & (P

8 -.P

8

' )

% ( I $0%

2 / 4 2± / 72 1 / 3 2± / 74 571 / 0 622 / 0

$6 76 5

/ 8 2± / 70 3 / 1 6± / 73 511 / 0

z>

' I $0%

72 / 3 1± / 20 1 / 2 97± / 20 731 / 0 58 / 0

$6 76 9

/ 2 2± / 21 2 / 2 2± / 23 566 / 0

VEGF ) pg/m ( I $0%

143 5± 147 1± 821 / 0 0001 / 0 *

$6 76 149

9± 177 2± 0001 / 0 *

NO ) 6 I 6 ( I $0%

22 / 2 1± / 15 9 / 9 0± / 15 666 / 0 0001 / 0 *

6

$6 7 5 / 22 1± / 16 1 / 1 1± / 21 003 / 0 *

FGF ) pg/m ( I $0%

77 / 15 1± / 6 79 / 36 1± / 6 634 / 0 0001 / 0 *

$6 76 2

/ 78 1± / 6 5 / 15 1± / 9 0001 / 0 *

) * 05 / P<0 ( .

6< / •! $ I $0% 6 )

D76 D/ t

6<

79 / 2 0Z6 BA/

821 / 0 ( D8 % ?

DD0Z6 DD/ -DD ? 6 4 DD .

DD ` ' "DD 6 -DD ! 76

2 DD.

5DD. ' DD6 <

' DD6 <

I DD$0% DD 4 DDVEGF

0Z6 8 &

' )

0001 / 0

= .(P

2 . - ! 76 5. ' 6 <

' 6 <

& 4 VEGF

= I $0%

1 / <

.

X 8 Z.3)VEGF& B]3 & B5.3 2 ..`; >'!$ . 1 Z . +.

(

^ !c ( E 8 ( (

/

134

96

I D^ D^ 6 D VE -D -^

1 D D6

4 ) 6 - ! 76 &

D9 2 D.

5D. ' D6 <

' D ' D6 <

6 '" 6 -% 9 $6 76 0! 3 & Z 9 6 <FGF

-^ -% -$ 0Z6 2!"#

D76 -D D6< D/ t

48 / 1 0Z6 BA/

0001 / 0 0Z6 ` '" 6 4!

.

6< / •! $ I $0% 6 )

D76 D/ t

6<

15 / 1 0Z6 BA/

634 / 0 ( D8 D % ?

0Z6 / - ? 6 4 .

D ` ' "D 6 -D ! 76

FGF

& I $0% 4 D0Z6 8

' D

) 001 / 0

= .(P

2 . - ! 76 5D. ' 6 <

' D6 <

4 D FGF

= I $0% &

2 / <

.

X 8 Z.)FGF & B]3 & B5.3 2 ..`; >'!$ .2 Z .

(

^ !c ( E 8 ( (

4 ) 6 - ! 76 2 D. D9

5D. ' D6 <

' D6 <

' D

6 ' " 6 -% 9 D0! 3 D& DZ D9 D6 <NO

0Z6 $6 76 .

D/ •! D$ I D$0% D D6

D0Z6 D8 D % ? 6<

D/ -D ? 6 4 D .

` ' " 6 - ! 76 4 0{39 I D$0% 4 NO

0Z6 8 &

' )

001 / 0

= )(P

= 3 (

N Z. )NO & B]3 & B5.3 2 ..`; >'!$ .3 Z . (

(

^ !c ( E 8 ( ( .

.8 W. 7

D $6 D76 4! D3 : D D/ -D Dl ? r 7h -$> . !" : 6 9 $% # .

D0 D6 9 $% # 4!

3 7 ! 7 : 6 27 -$

. ' D •! D$

DD0Z6 2!"DD# |DD $6 DD76 4! DD3 -DD$89 D! $D/ . ' E / - V$]6 ' 6 !" =6 '" 6 .

' D -D% ' D 39 D( B$D# -Z A6 •! $ -$# ! 4!

@ ADD/ 2!"DD# |D $6 DD76 4! DD3 -D$89 DD 9 D ' E / - V$]6 ' " !;<

Dv39 D 6 ' $ .

) 1 .(

' D 39 9 D -DZ A6 •! $ r 7h 4! •! $ : DD -DD%

6 '"DD 6 DD $6 7$DD/ 4! DD3 -DD$89

VEGF

-D V$D]6 ! hDN D9 T D6 D6 # 4 $/

v39 % / ' $ . ' E / .

D ' (<

D $6 7$/ 4! 3 2!"D# |

D! D9 T D6 VEGF

) 20 .(

D/ -D -D% ' 39 - 76 •! $ 4 0{39 -D V$D]6 D9 T D6 !" =6 9 0! 3 :

v39 0$> . ' $ . ' E / .

D rD 7h •! $

" D!;< =D6 2!"# | 9 4! 3 ' ' 39 6 ' $ . ' E / - V$]6 9 T .

-DZ A6 4D! •! D$

D0! 3 -D$89 -D/ ' -% ' 39 ' ^ r 7h 2!"# | $6 7$/

' E D/ -D V$D]6 D9 T 6VEGF

Dv39 ! .

"3 D D6 •! D$ D 4 D0{39

$6 7$/ 0! 3 : / - -% ' 39 T D6VEGF

D v39 0$> . ' $ . ' E / - V$]6 9 .

•! D$

|D $6 7$D/ 4! 3 ' ' 39 "3 r 7h @ A/ 29 % D! VEGF

) 18 .(

D rD 7h 4D! •! D$

' DD 39 " DD^ •! DD$

) 2015 ( DD DDv39 .

" DD^

% < 9 I / . > -Z A6 ' 39 6 0 D/

% 8$/ 9 T 6 )

16 .(

-D% ?

D> D6 =D? 6 -% 9 - 3 l ? r 7h D 8$D/ D D% E .

' D 39 " D^ 4 D0{39

29 D% | 0! 3 ' > -Z A6

VEGF

/

135

96

2!"# 6 # Vy VEGF

D ' D :

' E D/ -D V$D]6 D9 T 6 I $0% - ] 6 6 $/ . )

16 .(

! D/ D rD 7h 4D! ‰[ D0 =

D6 rD 7h =D . 9 6 < L - b 6 7 7h 6 ' E / L 4! 3 .

' D D6 rD 7h 4! ! " =6 2! "# = h6 D[ $6 D76 4! D3 : D h -% ! " 9 w

D% D 0$#

. -D 3&6 D! " D9 w Dh6

D6 D! ^ f = S! h Y^ 6 -% 0$ 9 =6 DD . DD9 DD % e! 9 =DD6 4DD! 4! DD UDD(6

DD00% L DD DD9 DD $6 6 D0! 39 DD[ DD9

$! / > Vy p ]7 4! %

2D % L D D9 D9

) 2 .(

D! " =6 2! "# N = % e! 9

/ . -D [ -$ 9 9 I / % e! 9 a!

09 k/ . '; % ]3%

. -D ' Do r 7h 9 - 3

D 4 0{9 6 =? 6 6 3 =i6 !R 3 6 R E Z#

-D D&06 $6 D76 0!

-D% / ! ' 3 4! % e! 9 a! 2! "#

4 W D. )3D o 2! "# a! 4!

mRNA

D % e! 9 D $% # )

HIF-1

( -D% D9 D6 }

$ D/ Vy ;! A ' $ . 9 # L 6 ' .

5 eD3%

HIF-1

D DZ D6 D =

' -D% D % e! 9 -D D09 20% N 0 00% ! / 0 [ -$ 9 -% q 9 9 )

21 ( -D%

' ! - &06 & / 6VEGF

. -D^

' Y^ 6 % e! 9 -%

zv 6 6VEGF

D9 D# L D ? 9 - 4 )3 o A

$6 6 8 .

D ' -0 6 7 7h

' - 0! 3 4 W . mRNA

VEGF

R

D 6 &06 .

2! "D# Y]D/ D[ D0! 3 3

D 4

|D 6 2! "# 4! -% 6 ' > ' ! ^ 6 0! 39 9 &!

) H $/

( 6 ) 22 .(

c06 D D6 6 D0! 39 D9 H $D/

D ' D> ' D! ^ w ADN -% / [ ! ^ D 6 =N ? ^ .

Y]D/ D3 DA H $D/ D

6 " !; < " ! <

. D? 2! "# / 6 c0

D00% L D BD YD^ 6 $ H $/ # ;! - [ 6NO

KD $6 f D rD! E 4!

6 . D ` Y]D/ H $D/ D 46"6 2! "# 6

6 f # e! 9 A[ 2! "# ;! - $> / ) 23 .(

-D ! 9 I % / I Z# r! E H $/

2! "D# D YD^ 6 3 D/ $. D9 I D % ;!

NO

DD6 DD Z# YDD^ 6 DD ` 4DD! DD DD9 DD

;! - 9 $% # 0 % 4!

D D6VEGF

.

rD! E H $D/ D -% / ' 4 0{39 DD0! )$0! 9 DD DD $% DD# ' DD YDD^ 6αvβ3

-! . /V ] # )

(bFGF

D[ I D D9 I /

2! "# - &06 $! ( -% 6 FGF

D D6 )

24 .(

@ AD/ ' < &06 -% 6 ! 4! 0

VEGF

D! I D$0% D -D ]D & $ 6 / YD^ 6 -% % 4! 3 # - y ' > ' ! ^ ' R

f ^ - $ H $/ 6

.

|D / 4 36 -% r 7h 4! 9 `$6 )! ! 2!"#

S! $ VEGF

% ) (NO

/ . D %

VDy f D D < aD/ ZDl 6 DA S! $ ' D> ' D! ^ -D k/ . p ]7 E Vy 9

D D6 B H $/ 2!"# ] - ! R .

KD]06

I D D9 I D/ S! $ % N

eNOS

-% 6 DE

I DZ# H $D/ D D 4! D3

DD6 DD ) 25 .(

9 )DD ? : DD DD $6 DD76 4! DD3

6 ) 4 W . - (G

I / d g -%

D^ I 9

Z# Y^ 6 D D$! ( eNOS

D D6 NO

) 15 .(

D !"# U Dc0 " !; < - =? 6 E

VEGF

< H $/ - '

=D? 6 D6 D/ -$ NO

/

136

96

D " !; < Z =7$D 6 " D!; < D0!< # NO

6VEGF

. 2!"D# =D!R ! ' 6 4 0{39 D9 I ! ? $6 76 0! 3 : NO

D D9 ' D % $ < 2!"# <

. D7 7h

' s $v6 2!"D# |D $6 76 0! 3 -% /

' D -D] s $v6 Z A6 6 < 9 I ! 0! 3 NO

) 15 .(

2! "DD# =DD!R 4 DD0{39 DD0! 3 DD: DD VEGF

D D 4! D < 2! "D# ' D D6 $6 76 .

4! D <

UDD $6 I DDPh6

ATP

DD DD6 .

DD]3% a! DD

4! D < (^ D =D [ 76 Vy p ]7 ! '; % 6 .

2! "D# 4! < -% ' 7 7h

d D7 VDy f D !_D. L D 2! "D# | -$# ! i 2! "# 9 $% # ' 2! "# I Z

D$! ( I D D9 I D/ ^ (6 f D = D

6 s $v6 9 # ! ^ )

26 .(

' D 39 !

-% '

50 D 70 a! D D! " kD/ . DN

D 6 & 6 4! < a/ % e! 9 )

17 .(

$6 D76 D0! 3 -% ! & < 9 $6 ! / -A D$%R 0% 6 $%R ? - D/ D

S! h D9 I D/ a/ 9 /V ] # VEGF

9 6 -Z/ ' V% "$0/ 9 # % 6 I .

'

rD! E U 7$D 6 D g DA D$%R -D% / D 2! "#

I D D9 I D/ ^ D(6VEGF

0% 6 & 6 )

17 .(

[ 0! 3 -% ! & <

D9 2D % D D39

D6 4! D0 D/ D39 $/ 2 % -> o 4D! D! " =D6 2! "# = # -& $ '

D D6 S $D ! 2D % -> o 2 % r 7h .

D[ I 9 I / (0 -% H $/ 5 -D D&06 2D % ! I 3 9 6 [ : h D/ 6 -D 3^ 9 I / Z / s E / I Z#

D/V ] # 9 6 9 I / $ / - y 9 / . [ q N - y 9 I / $# 4 9

6 I 9 I / 9

. D/ D ' D

L D -D -$D SD !; < D9 $% # BD ' " 6 -%

I 3 w h6 @ AD/ BD / 8$6

MMP

rD! E D 6 [ 2 % h - y -% 6 (0

6 ! ^ f = | ' - ^

) 26 .(

9 - 3^ " $ / - y p ]7 % A 2! "# =7$ 6 E - -% / f ƒ > 6

Dy D! " D0!< # - y ' > ' ! ^ $ D/ -

0% 6 S! h .

$ / - y l ]7 > 4! 0

" !; < =6 6 =7$ 6 E - [ % ? ' 3 4!

.

D# -D% D D6 - Dl # 4D! D 6 D3 7 -D -D^ ! " - > E /

D/ -D V$D]6 ' D3 - Dl # 4D!

: DD =D -D ' E

0! 3 Z# ! " =6

D&

' D D6 D7 7h ! D/ •! D$ - -^ 09 3 $6 D76 4! 3 - 3^ Z# -% # -& $ D! " r! E Vy # - ! _g 6 •_^ |

- E / # / $/ 29 % -& $ ! _Dg 6

D 6 E / # K 6 -& $ 6 .

|D 6 $6 76 4! 3 / 6 c - 4! 0 -D V$D]6 ' D6 SD! . a! D " !; < ` S! !" # a! - $/ . ' E / .

( \ Z/;

. ' E / - V$]6 # 6 3 D6 -D% $/

D[ D D 3 D! rD 7h 4! ' &

6 U! 3 - 76 4! .

ƒ v$ 6 DPPv D$% - D/

% (D )D U $6 3

• DP6

22 / 12 / 95 6 .

/

137

96 References

1. Fathollahi Shoorabeh F, Dabidiroshan V, Sheikh Saraf B, Nuri R. Investigating the Effects of Regular Resistance Training and Prostatic Massage on Proinflammatory Markers and Serum Prostate-Specific Antigen Levels in Males with Prostate Cancer, Middle East J Rehabil Health Stud.

2016 ;3(1):e33651.

2. Rafiemanesh H, Enayatrad M, Salehiniya H.

Epidemiology and Trends of Mortality from prostate cancer in Iran. J Isfahan Med Sch.

2015; 33(330): 515-21.

3. Clemons M, Danson S, Howell A.

Tamoxifen (‘Nolvadex’): a review:

Antitumour treatment. Cancer Treat Rev 2002; 28(4):165-180.

4. Farzanegi P, Habibian M, Delavari H. The effect of aerobic exercise on the levels of vascular endothelialgrowth factor and glucose in hypertensive postmenopausal women: a randomized clinical trial. Qom Univ Med Sci. 2014; 8(4): 6-12. (In Persian) 5. Tayebe RT, Baharara J. A review on

Angiogenesis in Tumor. J Cell Tissue. 2014;

5(1): 89-100.

6. Jahani M, HoseinModaressi M, Mansouri K.

Hypoxia inducible factor: It’s role in angiogenesis and tumor. Tehran Univ Med J.

2016; 173(11): 757-766.

7. Semenza GL. HIF-1: using two hands to flip the angiogenics witch. Cancer Metastasis Rev. 2000;19(1-2): 59-65.

8. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971; 285(21):

1182-1186.

9. Pedersen BK. Exercise-induced myokines and their role in chronic diseases. Brain Behav Immun. 2011; 25(2): 811-816.

10.Kamat A, Rajoria S, George A, Suriano R, Shanmugam A, Megwalu U, et al. Estrogen- mediated angiogenesis in thyroid tumor microenvironment is mediated through VEGF signaling pathways. Arch Otolaryngol Head Neck Surg. 2011;

137(11): 1146-1153.

11.Ghosh S, Ashcraft K. An IL-6 link between obesity and cancer. Frontiers Biosci. 2012;

5(1): 461-478.

12.Langston W, Childow JH, Booth BH, Barlow SC, Lefer DJ, Patel RP, et al.

Regulation of endothelial glutathione by ICAM-1 governs VEGF-A-mediated eNOS activity and angiogenesis. Free Radic Biol Med. 2007; 42(5): 720-729.

13.Sasser AK, Sullivan NJ, Studebaker AW, Hendey LF, Axel AE, Hall BM. Interleukin- 6 is a potent growth factor for ER-α-positive human breast cancer. FASEB J. 2007;

21(13): 3763-3770.

14.Schneider BP, Miller KD. Angiogenesis of breast cancer. J Clin Oncol. 2005; 23(8):

1782-1790.

15.Shekarchizadeh P, Khazaei M, Gharakhanlou R, Karimian Safarzadeh A.

The Effects of Resistance Training on Plasma Angiogenic Factors in Normal Rats.

J Isfahan Med School .2012; 20(30): 176- 180.

16.Jones LW, Antonelli J, Masko EM, Broadwater G, Lascola CD, Fels D. et al.

Exercise modulation of the host-tumor

/

138

96

interaction in an orthotopic model of murine prostate cancer. Appl Physiol. 2012; 113(2):

263-272.

17.Fathollahi F, Tarverdizadeh B, Kheyhani M.

The impact of eight weeks of resistance training on some angiogenesis indicators in women with breast cancer. Iranian J Obstet, Gyneco Infertil. 2017; 20(3): 9-17.

18.Amani-Shalamzari S, Aghaalinejad H, Alizadeh S, Kazmi A, Saei MA, Minayi N, et al . The effect of endurance training on the level of tissue IL-6 and VEGF in mice with breast cancer. J Shahrekord Univ Med Sci.

2014; 16(2):10-21.

19.Ergun M, Eyigor B. Kara C. Effects of exercise on angiogenesis and apoptosis- related molecules, quality of life, fatigue and depression in breast cancer patients. Europ J Cancer Care. 2013; 22: 626-637.

20.Noorshahi M, Babaei A, Bigdeli MR, Ghasemi BM. The effect of six weeks of resistance training on tumor tissue VEGF and endostatin in mice with breast cancer.

Sport Biosc. 2013; 5(17): 27-46. (In Persian) 21.Myllyharju J, Koivunen P. Hypoxia- inducible factor prolyl 4-hydroxylases:

common and specific roles. Biol Chem.

2013; 394(4): 435-448.

22.Greer SN, Metcalf JL, Wang Y, Ohh M. The updated biology of hypoxia-inducible factor.

EMBO J. 2012; 31(11): 2448-2460.

23.Friedmann B, Frese F, Menold E, Bartsch P.

Effects of acute moderate hypoxia on anaerobic capacity in endurance-trained runners. Eur J Appl Physiol. 2007; 101(1):

67-73.

24.Pirouz M, Nourshahi M. The effect of eight weeks training in hypoxia-normobaric and normal situation on serum VEGF, erythropoietin concentration, fatigue index and VO2max. Quart J Sport Biosci Res.

2013; 3(10): 19-31. (In Persian)

25.Zielinski MR, Muenchow M, Wallig MA, Horn PL, Woods JA. Exercise delays allogeneic tumor growth and reduces intra tumoral inflammation and vascularization. J Appl Physiol. 2004; 96(6): 2249-2256.

26.Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti- inflammatory effects of exercise:

mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011; 11(9): 607-615.

/

139

96

The Effects of Ten Weeks Resistance Training on Resting Levels of Some Angiogenesis Factors Among Men with Prostate Cancer

Fathollahi shoorabeh F,¹ Faramarzi M^*2, Hemmati R³, Nuri R⁴

1. PhD Student in Sport Physiology, Department of Sport Sciences, Faculty of Humanities , Shahrekord University, Shahrekord, Iran

2. Associate Professor, Department of Sport Physiology, Faculty of Humanities, Shahrekord University, Shahrekord, Iran, md.faramarzi@gmail.com

3.Assistant Professor, Department of Biology, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran.

4.Assistant Professor, Department of Sport Sciences, Faculty of Humanities, Kish International Campus, Tehran.

Received: 25 Sep 2017 Accepted: 20 Nov 2017

Abstract

Background: Prostate cancer is the second most prevalent canceramong men and the eighth leading cause of death in Iran. In pathological conditions, angiogenesis increases the chance of metastasis and thus spreads cancer. The aim of the present study was to examine the effects of 10 weeks of resistance training on some angiogenesis factors among men affected by prostate cancer.

Materials and Methods: ^Twenty men with prostate cancer aged between 55 and 62 were selected and randomly divided into control (n=10) and resistance training groups (n=10). The experimental group performed 10 weeks of resistance training, three sessions per week. Each exercise includes three sets of twelve repetitions with the intensity of 50-65 percent of 1RM. In order to measurement of NO, FGF and VEGF, blood samples were taken from the participants after 12 hours fasting state 24 hours before and 48 after the last training. For comparison of means between and within group's independent and dependent T test were used, respectively.

Results:The results showed that ten weeks of resistance training significantly increase the levels of VEGF ( P=0.0001), FGF (P=0.0001) and NO (P=0.0003) in men suffering from prostate cancer.

Conclusion: It appears 10 weeks of resistance training cause increase the level of angiogenesis factors, muscular strength and mass and decrease fatigue in men affected by prostate cancer.

Keywords: Resistance Training, Prostate Cancer, Angiogenesis.

*Citation: Fathollahi shoorabeh F, Faramarzi M, Hemmati R, Nuri R. The Effects of Ten Weeks Resistance Training on Resting Levels of Some Angiogenesis Factors Among Men with Prostate Cancer. Yafte. 2017; 19(4):129-139.